EXAS Jun 2024 60.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:49PM EDT. Market open.
| Previous close | 1.1000 |
| Open | 0.3500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 60.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.3500 - 1.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireCourt Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
MADISON, Wis., May 21, 2024--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that a District Court judge denied in part Geneoscopy’s (defendant) motion to dismiss a patent infringement lawsuit filed by Exact Sciences (plaintiff) in the United States District Court for the District of Delaware. This ruling paves the way for Exact Sciences to seek relief for Geneoscopy’s future infringement and false advertising.
Simply Wall St.Exact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
There's been a notable change in appetite for Exact Sciences Corporation ( NASDAQ:EXAS ) shares in the week since its...
- GuruFocus.com
Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss
Comparative Analysis of Q1 Performance Against Analyst Projections
© 2024 Yahoo. All rights reserved.